The implications of impaired glucose tolerance after kidney transplantation
Francis J. Tinney(Henry Ford Health System), Colleen L. Jay(Northwestern University), Diane M. Cibrik(University of Kansas), Milagros Samaniego(Henry Ford Health System), Randall S. Sung(University of Michigan), Mark D. Stegall(Mayo Clinic in Arizona), Abhijit S. Naik(University of Michigan), Silas P. Norman(University of Michigan), D Frietze
Unknown
January 1, 2018
Cited by 0
Related Papers
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update
|American Journal of Kidney Diseases|2015|1.3k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k
Ischemic Cholangiopathy After Controlled Donation After Cardiac Death Liver Transplantation
|Annals of Surgery|2011|309
Plasmapheresis, CMV Hyperimmune Globulin, and Anti-CD20 Allow ABO-Incompatible Renal Transplantation Without Splenectomy
|American Journal of Transplantation|2004|283
Adverse Outcomes of Tacrolimus Withdrawal in Immune–Quiescent Kidney Transplant Recipients
|Journal of the American Society of Nephrology|2015|193